Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Dual Therapy in Real Life Setting in Treatment-Naïve Turkish Patients with HCV Infection: A Multicenter, Retrospective Study.
Gürbüz Y, Tülek NE, Tütüncü EE, Koruk ST, Aygen B, Demirtürk N, Kınıklı S, Kaya A, Yıldırmak T, Süer K, Korkmaz F, Ural O, Akhan S, Günal Ö, Tuna N, Köse Ş, Gönen İ, Örmen B, Türker N, Saltoğlu N, Batırel A, Tuncer G, Bulut C, Sırmatel F, Ulçay A, Karagöz E, Tosun D, Şener A, Aynıoğlu A, Altunok ES. Gürbüz Y, et al. Among authors: demirturk n. Balkan Med J. 2016 Jan;33(1):18-26. doi: 10.5152/balkanmedj.2015.15859. Epub 2016 Jan 1. Balkan Med J. 2016. PMID: 26966614 Free PMC article.
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B.
Guclu E, Tuna N, Karabay O, Akhan S, Bodur H, Ceylan B, Demirdal T, Demirdag K, Demirturk N, Ekerbicer H, Erol S, Esen S, Evirgen O, Geyik MF, Gunduz A, Karahocagil MK, Kokoglu OF, Ozdemir D, Ozgunes N, Sargın F, Tosun S, Tutuncu E. Guclu E, et al. Among authors: demirturk n. J Infect Dev Ctries. 2014 Dec 15;8(12):1601-8. doi: 10.3855/jidc.4953. J Infect Dev Ctries. 2014. PMID: 25500658 Free article.
Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C.
Sargin Altunok E, Sayan M, Akhan S, Aygen B, Yildiz O, Tekin Koruk S, Mistik R, Demirturk N, Ural O, Kose Ş, Aynioglu A, Korkmaz F, Ersoz G, Tuna N, Ayaz C, Karakecili F, Keten D, Inan D, Yazici S, Koculu S, Yildirmak T. Sargin Altunok E, et al. Among authors: demirturk n. Int J Infect Dis. 2016 Sep;50:1-5. doi: 10.1016/j.ijid.2016.07.003. Epub 2016 Jul 9. Int J Infect Dis. 2016. PMID: 27401586 Free article.
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience.
Aygen B, Demirtürk N, Yıldız O, Çelen MK, Çelik İ, Barut Ş, Ural O, Batırel A, Mıstık R, Şimşek F, Asan A, Ersöz G, Türker N, Bilgin H, Kınıklı S, Karakeçili F, Zararsız G, Turkish Society Of Clinical Microbiology And Infectious Diseases TSGFVHOT. Aygen B, et al. Among authors: demirturk n. Turk J Gastroenterol. 2020 Apr;31(4):305-317. doi: 10.5152/tjg.2020.19197. Turk J Gastroenterol. 2020. PMID: 32412901 Free PMC article.
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
Demirtürk N, Aygen B, Çelik İ, Mıstık R, Akhan S, Barut Ş, Ural O, Batırel A, Şimşek F, Ersöz G, İnan D, Kınıklı S, Türker N, Bilgin H, Gürbüz Y, Tülek N, Tarakçı H, Yıldız O, Türkoğlu E, Kamalak Güzel D, Şimşek S, Tuna N, Aktuğ Demir N, Çağatay A, Çetinkaya RA, Karakeçili F, Hakyemez İN, Tuncer Ertem G, Örmen B, Korkmaz P, Yıldız U, Kuruüzüm Z, Şener A, Arslan Özel S, Öztürk S, Suer K, Çelen MK, Konya P, Asan A, Saltoğlu N, Doğan N. Demirtürk N, et al. Turk J Gastroenterol. 2021 Feb;32(2):155-163. doi: 10.5152/tjg.2020.19569. Turk J Gastroenterol. 2021. PMID: 33960939 Free PMC article.
Treatment initiation rates of patients with positive anti-hepatitis C virus results in tertiary hospitals in Turkey.
Çelen MK, Ertürk Şengel B, Kaya Ş, Demirtürk N, Azap A, Pullukçu H, Eroğlu E, Yıldırım F, Barut HŞ, Zerdali E, Sağmak Tartar A, Mete AÖ, Şahin AM, Mutay Suntur B, Sarı ND, Yılmaz E, Candevir A, Şimşek F, İnan D, Akhan S, Asan A, Günal Ö, Ural O, Parlak M, Çabalak M, Nazik S, Hızel K, Kınıklı S, Beştepe Dursun Z, Batırel A, Mermutluoğlu Ç. Çelen MK, et al. Among authors: demirturk n. J Infect Dev Ctries. 2024 Mar 31;18(3):441-449. doi: 10.3855/jidc.17910. J Infect Dev Ctries. 2024. PMID: 38635621 Free article.
Impact of the COVID-19 Pandemic on Diabetic Foot Patients: A Shift in the Infectious Agent Profile Toward Nonfermentative Gram-Negative Bacilli.
Acar A, Saltoğlu N, Tülek N, Turhan Ö, Serin EN, Yapar D, Kendirci M, Sürme S, Karaca BY, Altay FA, Tayşi R, Şencan İ, Tanyel E, Bilek HC, Güler Ö, Mutlu B, Aksan T, Karadağ FY, Kadanalı A, Altunal LN, Oglu MC, Şenbayrak S, Erol S, Ak Ö, Aladağ N, Demirtürk N, Konya P, Bulut D, Engin DÖ, Aslan HM, Kaya SD. Acar A, et al. Among authors: demirturk n. J Am Podiatr Med Assoc. 2024 May-Jun;114(3):22-073. doi: 10.7547/22-073. J Am Podiatr Med Assoc. 2024. PMID: 39058633
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data.
Gürbüz Y, Kocagül-Çelikbaş A, Öztoprak N, Aygen B, Batırel A, Habiloğlu AD, Aktuğ-Demir N, Çeken S, Demirtürk N, Ceylan MR, Üçer Ş, Karakeçili F, Alkan S, İnce N, Akça A, Günay V, Mustanoğlu-Özatağ D, Çınar G, Kınıklı S, Yıldız O, Şarlak-Konya P, Sümer Ş, Yekenkurul D, Çelik M, Binay UD, Aşık-Otman Z. Gürbüz Y, et al. Among authors: demirturk n. Infect Dis Clin Microbiol. 2024 Sep 26;6(3):216-224. doi: 10.36519/idcm.2024.344. eCollection 2024 Sep. Infect Dis Clin Microbiol. 2024. PMID: 39399749 Free PMC article.
46 results